1. Home
  2. ETNB vs MTAL Comparison

ETNB vs MTAL Comparison

Compare ETNB & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • MTAL
  • Stock Information
  • Founded
  • ETNB 2018
  • MTAL 2021
  • Country
  • ETNB United States
  • MTAL Jersey
  • Employees
  • ETNB N/A
  • MTAL N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • MTAL Blank Checks
  • Sector
  • ETNB Health Care
  • MTAL Finance
  • Exchange
  • ETNB Nasdaq
  • MTAL Nasdaq
  • Market Cap
  • ETNB 867.4M
  • MTAL 1.0B
  • IPO Year
  • ETNB 2019
  • MTAL 2021
  • Fundamental
  • Price
  • ETNB $8.04
  • MTAL $10.86
  • Analyst Decision
  • ETNB Buy
  • MTAL Buy
  • Analyst Count
  • ETNB 7
  • MTAL 2
  • Target Price
  • ETNB $30.33
  • MTAL $15.50
  • AVG Volume (30 Days)
  • ETNB 800.5K
  • MTAL 214.0K
  • Earning Date
  • ETNB 11-07-2024
  • MTAL 01-01-0001
  • Dividend Yield
  • ETNB N/A
  • MTAL N/A
  • EPS Growth
  • ETNB N/A
  • MTAL N/A
  • EPS
  • ETNB N/A
  • MTAL N/A
  • Revenue
  • ETNB N/A
  • MTAL $322,583,000.00
  • Revenue This Year
  • ETNB N/A
  • MTAL $135.15
  • Revenue Next Year
  • ETNB N/A
  • MTAL $13.47
  • P/E Ratio
  • ETNB N/A
  • MTAL N/A
  • Revenue Growth
  • ETNB N/A
  • MTAL 1636.56
  • 52 Week Low
  • ETNB $7.00
  • MTAL $9.89
  • 52 Week High
  • ETNB $16.63
  • MTAL $15.26
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 44.02
  • MTAL 34.87
  • Support Level
  • ETNB $7.44
  • MTAL $12.19
  • Resistance Level
  • ETNB $8.09
  • MTAL $13.35
  • Average True Range (ATR)
  • ETNB 0.44
  • MTAL 0.42
  • MACD
  • ETNB -0.06
  • MTAL -0.17
  • Stochastic Oscillator
  • ETNB 22.47
  • MTAL 0.00

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About MTAL Metals Acquisition Limited

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the global economy.

Share on Social Networks: